Trellus Management Company, LLC Accelerate Diagnostics, Inc Call Options Transaction History

Trellus Management Company, LLC

  • $69.9 Million
  • Q3 2023

Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2018

Feb 04, 2019
BUY
$10.42 - $21.94 $635,620 - $1.34 Million
61,000 New
61,000 $702,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Trellus Management Company, LLC Portfolio

Follow Trellus Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellus Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email